ABCL Competitors & Alternatives
Compare Abcellera Biologics Inc with similar stocks in the same industry
Biotechnology
ABCL
Main Stock$8.11
Tradestie Score
59
Market Cap
$1.78B
Revenue Growth
1.0%
Analyst Upside
+28.6%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$146.63
|
$2.41B | - | 58 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$37.65
|
$2.40B | - | 60 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 60 | Compare |
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$25.81
|
$2.37B | - | 59 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$132.91
|
$2.35B | - | 59 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$9.44
|
$2.34B | - | 56 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$76.26
|
$2.33B | - | 64 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$37.58
|
$2.33B | - | 59 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 59 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.80
|
$2.23B | - | 57 | Compare |
More ABCL Analysis
Data updated: Jul 03, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry